Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.00949683 | 0.5 | 0.5 |
Trypanosoma cruzi | monoglyceride lipase, putative | 0.00949683 | 0.5 | 0.5 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.00949683 | 0.5 | 0.5 |
Plasmodium falciparum | esterase, putative | 0.00949683 | 0.5 | 0.5 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.00949683 | 0.5 | 0.5 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.00949683 | 0.5 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.00949683 | 0.5 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.00949683 | 0.5 | 0.5 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.00949683 | 0.5 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.00949683 | 0.5 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.00949683 | 0.5 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.00949683 | 0.5 | 0.5 |
Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.00949683 | 0.5 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.00949683 | 0.5 | 0.5 |
Mycobacterium tuberculosis | Possible lysophospholipase | 0.00949683 | 0.5 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.00949683 | 0.5 | 0.5 |
Leishmania major | monoglyceride lipase, putative | 0.00949683 | 0.5 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.00949683 | 0.5 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.00949683 | 0.5 | 0.5 |
Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.00949683 | 0.5 | 0.5 |
Plasmodium vivax | PST-A protein | 0.00949683 | 0.5 | 0.5 |
Mycobacterium ulcerans | lysophospholipase | 0.00949683 | 0.5 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.00949683 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 0.017 uM | Antiparasitic activity against chloroquine-sensitive Plasmodium falciparum NF54 in red blood cells by [3H]hypoxanthine incorporation assay | ChEMBL. | 17280835 |
IC50 (functional) | = 0.017 uM | Antiparasitic activity against chloroquine-sensitive Plasmodium falciparum NF54 in red blood cells by [3H]hypoxanthine incorporation assay | ChEMBL. | 17280835 |
IC50 (functional) | = 0.061 uM | Antiparasitic activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 in red blood cells by [3H]hypoxanthine incorporation assay | ChEMBL. | 17280835 |
IC50 (functional) | = 0.061 uM | Antiparasitic activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 in red blood cells by [3H]hypoxanthine incorporation assay | ChEMBL. | 17280835 |
IC50 (ADMET) | = 11 uM | Cytotoxicity against L6 cells | ChEMBL. | 17280835 |
Ratio IC50 (functional) | = 0.28 | Ratio of IC50 for Plasmodium falciparum NF54 to IC50 for Plasmodium falciparum K1 | ChEMBL. | 17280835 |
Ratio IC50 (functional) | = 0.28 | Ratio of IC50 for Plasmodium falciparum NF54 to IC50 for Plasmodium falciparum K1 | ChEMBL. | 17280835 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | 17280835 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.